Its biggest fraud is in insinuating that their assays prove that e-cigs can cause cancer. "One of the most pertinent questions regarding the relative safety of e-cigs is whether or not e-cigs have the potential to cause DNA damage in human cells," they slime. But
those assays have not been validated to be able to predict this! And in fact, a similar Comet assay was shown by a prospective study NOT to do so!
In Epstein-Barr virus-transformed lymphoblastoid cell lines established from prospectively collected peripheral blood samples of 117 lung cancer patients with 117 matched controls,
the alkaline Comet assay and the host cell reactivation (HCR) assay with the mutagen benzo[a]pyrene diol epoxide were unrelated to lung cancer risk. In the bleomycin mutagen sensitivity assay, "statistically significantly increased lung cancer odds ratios (OR(adjusted)) were observed for bleomycin mutagen sensitivity as quartiles of chromatid breaks/cell [relative to the lowest quartile, OR = 1.2, 95% confidence interval (CI): 0.5-2.5; OR = 1.4, 95% CI: 0.7-3.1; OR = 2.1, 95% CI: 1.0-4.4, respectively, P(trend) = 0.04]. The magnitude of the association between the bleomycin assay and lung cancer risk was modest compared with those reported in previous lung cancer studies but was strengthened when we included only incident cases diagnosed more than a year after blood collection (P(trend) = 0.02), supporting the notion the assay may be a measure of cancer susceptibility." [However, infections by both Epstein-Barr virus and cytomegalovirus make cells more susceptible to damage by bleomycin.]
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial